Autonomix Medical, Inc. (AMIX)
Q2-CY2026Q1-CY2026Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014Q2-CY2014
Balance Sheet Date2026-Mar-312025-Dec-312025-Sep-302025-Jun-302025-Mar-312024-Dec-312024-Sep-302024-Jun-302024-Mar-312023-Dec-31
Fiscal PeriodQ4-FY2026Q3-FY2026Q2-FY2026Q1-FY2026Q4-FY2025Q3-FY2025Q2-FY2025Q1-FY2025Q4-FY2024Q3-FY2024
Operating Cash Flow(2,892,000$)(2,969,000$)(3,817,000$)(2,604,000$)(8,258,000$)(2,301,000$)(1,596,000$)(1,852,000$)(6,648,000$)(1,144,000$)(661,000$)(620,000$)
Investing Cash Flow(3,000$)(14,000$)(5,000$)0$(5,000$)(19,000$)
Purchases of Property and Equipment3,000$14,000$5,000$0$5,000$19,000$
Financing Cash Flow(35,000$)5,433,000$2,705,000$2,057,000$8,800,000$14,410,000$350,000$2,735,000$
End Cash Position7,004,000$9,934,000$7,477,000$8,589,000$9,136,000$11,823,000$5,155,000$6,751,000$8,608,000$1,218,000$865,000$810,000$
Exchange Rate Effect
Dividends Paid
Unlevered Free Cash Flow(2,895,000$)(2,969,000$)(3,817,000$)(2,604,000$)(8,272,000$)(2,306,000$)(1,596,000$)(1,857,000$)(6,667,000$)(1,144,000$)(661,000$)(620,000$)